Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial)

Cardiovascular Revascularization Medicine

Volumn 15, Issue 4, 2014, Pages 204-208

  Bhatt, Parloop ^a   Parikh, Parth ^a   Patel, Apurva ^b   Chag, Milan ^a   Chandarana, Anish ^a   Parikh, Roosha ^b   Parikh, Keyur ^a  

^a Care Institute of Medical Sciences   (India)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherectomy; Coronary artery disease; Orbital atherectomy; Percutaneous intervention

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISSECTION; CORONARY STENT; DRUG ELUTING STENT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; MALE; MULTICENTER STUDY; ORBITAL ATHERECTOMY DEVICE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; Q WAVE; ATHERECTOMY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEVICES; EQUIPMENT DESIGN; FEASIBILITY STUDY; HEART CATHETER; INDIA; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; SEVERITY OF ILLNESS INDEX; STENT; TIME; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

ATHERECTOMY, CORONARY; CARDIAC CATHETERS; CORONARY ARTERY DISEASE; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 84902545632     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2014.03.004     Document Type: Article

References (23)

1. US Markets for Interventional Cardiology Devices 2013. RPUS10IC12 2012, 59. Millennium Research Group, Toronto.
2. Mintz G.S., Popma J.J., Pichard A.D., Kent K.M., Satler L.F., Chuang Y.A., et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 1995, 91(7):1959-1965.
3. Onuma Y., Tanimoto S., Ruygrok P., Neuzner J., Piek J.J., Seth A., et al. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv 2010, 76(5):634-642.
4. Benezet J., Díaz de la Llera L.S., Cubero J.M., Villa M., Fernández-Quero M., Sánchez-González A. Drug-eluting stents following rotational atherectomy for heavily calcified coronary lesions: long-term clinical outcomes. J Invasive Cardiol 2011, 23(1):28-32.
5. Levine G.N., Bates E.R., Blankenship J.C., Bailey S.R., Bittl J.A., Cercek B., et al. ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011, 58(24):e44-e122.
6. Serruys P.W., Degertekin M., Tanabe K., Abizaid A., Sousa J.E., Colombo A., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002, 106(7):798-803.
7. Hong M.K., Mintz G.S., Lee C.W., Song J.M., Han K.H., Kang D.H., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 2003, 107(4):517-520.
8. Gershlick A., De Scheerder I., Chevalier B., Stephens-Lloyd A., Camenzind E., Vrints C., et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 2004, 109(4):487-493.
9. Lansky A.J., Costa R.A., Mintz G.S., Tsuchiya Y., Midei M., Cox D.A., et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation 2004, 109(16):1948-1954.
10. Moses J.W., Carlier S., Moussa I. Lesion preparation prior to stenting. Rev Cardiovasc Med 2004, 5(Suppl. 2):S16-S21.
11. Matsuo H., Watanabe S., Watanabe T., Warita S., Kojima T., Hirose T., et al. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy-a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil. Am Heart J 2007, 154(5):994.e1-994.e6.
12. Kume T., Okura H., Kawamoto T., Akasaka T., Toyota E., Neishi Y., et al. Assessment of the histological characteristics of coronary arterial plaque with severe calcification. Circ J 2007, 71(5):643-647.
13. Parikh K., Chandra P., Choksi N., Khanna P., Chambers J. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial. Catheter Cardiovasc Interv 2013, 81(7):1134-1139.
14. Rogers J.H., Lasala J.M. Coronary artery dissection and perforation complicating percutaneous coronary intervention. J Invasive Cardiol 2004, 16(9):493-499.
15. Hoffmann R., Mintz G.S., Popma J.J., Satler L.F., Kent K.M., Pichard A.D., et al. Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J 1998, 19(8):1224-1231.
16. Brogan W.C., Popma J.J., Pichard A.D., Satler L.F., Kent K.M., Mintz G.S., et al. Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol 1993, 71(10):794-798.
17. Moussa I., Di Mario C., Moses J., Reimers B., Di Francesco L., Martini G., et al. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation 1997, 96(1):128-136.
18. Kereiakes D.J., Turco M.A., Breall J., Farhat N.Z., Feldman R.L., McLaurin B., et al. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv 2008, 1(3):248-257.
19. Kini A., Marmur J.D., Duvvuri S., Dangas G., Choudhary S., Sharma S.K. Rotational atherectomy: improved procedural outcome with evolution of technique and equipment. Single-center results of first 1,000 patients. Catheter Cardiovasc Interv 1999, 46(3):305-311.
20. Adams G.L., Khanna P.K., Staniloae C.S., Abraham J.P., Sparrow E.M. Optimal techniques with the Diamondback 360° System achieve effective results for the treatment of peripheral arterial disease. J Cardiovasc Transl Res 2011, 4(2):220-229.
21. Clavijo L.C., Steinberg D.H., Torguson R., Kuchulakanti P.K., Chu W.W., Fournadjiev J., et al. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv 2006 Dec, 68(6):873-878.
22. Mosseri M., Satler L.F., Pichard A.D., Waksman R. Impact of vessel calcification on outcomes after coronary stenting. Cardiovasc Revasc Med 2005, 6(4):147-153.
23. Abdel-Wahab M., Richardt G., Joachim Büttner H., Toelg R., Geist V., Meinertz T., et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv 2013, 6(1):10-19.